埃文斯综合征
医学
抗磷脂综合征
狼疮抗凝剂
前瞻性队列研究
危险系数
比例危险模型
内科学
痹症科
队列
免疫学
队列研究
羟基氯喹
单中心
自身免疫性溶血性贫血
红斑狼疮
儿科
贫血
生存分析
血液学
系统性红斑狼疮
结缔组织病
自身免疫
免疫病理学
免疫球蛋白M
作者
Vicente Baca,Daniel Hernández-López,Sonia González-Muñiz,Miguel Ángel Villasís-Keever,Mayra R. Arcos‐Cruz,Ana P.G. Marín‐Hernández,Francisco Martin Barajas-Olmos
摘要
OBJECTIVE: The aim of this study was to characterize the long-term clinical course of children with hematologic noncriteria manifestations and persistent antiphospholipid antibodies (aPLs) and to identify predictors of progression to antiphospholipid syndrome (APS) and/or systemic lupus erythematosus (SLE). METHODS: We conducted a prospective cohort study of children (<18 years old) with persistent aPL positivity and hematologic involvement (thrombocytopenia, autoimmune hemolytic anemia [AIHA], or Evans syndrome) observed at a tertiary pediatric rheumatology center between 1995 and 2024, with follow-up extending into adulthood. Progression to clinically classifiable APS and/or SLE was the primary endpoint. Kaplan-Meier and Cox proportional hazards models evaluated predictors at presentation and in complementary time-dependent analyses. RESULTS: Among 42 enrolled children, 40 were evaluable, of whom 11 (27.5%) progressed to APS and/or SLE. Evans syndrome at presentation was associated with the highest hazard of progression compared with isolated thrombocytopenia (hazard ratio 6.21, 95% confidence interval 1.46-26.41). In time-dependent analyses, Evans syndrome emerging during follow-up remained associated with progression. Isolated thrombocytopenia showed the lowest risk, whereas AIHA represented an intermediate state that did not independently predict progression. Lupus anticoagulant was nearly universal, and broader high-risk aPL profiles were more common among progressors but were not statistically significant. CONCLUSION: In children with persistent aPL positivity, Evans syndrome was the hematologic phenotype most strongly associated with progression to APS and/or SLE, whereas isolated thrombocytopenia followed a largely indolent course. Evolving hematologic phenotypes may improve risk stratification and inform long-term monitoring strategies within the APS-SLE spectrum.
科研通智能强力驱动
Strongly Powered by AbleSci AI